["{\n\"step_by_step_thinking\": \"The patient presents with fatigue after starting chemotherapy for metastatic breast cancer. Her blood counts show a decrease in leukocyte count (800/mm3 to 2,000/mm3) and an increase in platelet count (50,000/mm3 to 56,000/mm3). The hemoglobin level remains stable. Given the changes in blood counts, it is likely that the new medication is affecting the patient's bone marrow. This suggests a drug that stimulates or supports hematopoiesis.\",\n\"answer_choice\": \"D: Romiplostim\"\n}"]